Activist investor William Ackman said on Monday that Allergan Inc's (AGN.N) chief executive has a "disabling" conflict of interest because accepting a takeover by Valeant Pharmaceuticals International (VRX.N) (VRX.TO) likely means he would lose his job.
Read more »
